Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1990 Nov;28(11):2500–2506. doi: 10.1128/jcm.28.11.2500-2506.1990

Epitopes functional in neutralization of varicella-zoster virus.

B Forghani 1, K W Dupuis 1, N J Schmidt 1
PMCID: PMC268214  PMID: 1701445

Abstract

By competition neutralization assay using monoclonal antibodies (MAbs) to varicella-zoster virus (VZV) glycoproteins (gps), we attempted to determine the topographical relationship of epitopes which are functional in VZV neutralization. MAbs against gpI interfered moderately to strongly with neutralization of MAbs against gpIII, and one antigenic domain with two distinct epitopes was identified on gpIII. Competition neutralization assays performed with MAbs to gpI revealed at least three distinct antigenic domains: the first contained two complement-dependent neutralizing epitopes; the second contained five complement-dependent neutralizing, overlapping epitopes and one nonneutralizing, nonoverlapping epitope; and the third contained one complement-enhanced neutralizing epitope. Competition neutralization assays performed with MAbs to gpIV showed one antigenic domain with two distinct epitopes which competed with nonneutralizing gpI MAbs. gpII did not interfere with neutralization of gpI, gpIII, or gpIV. Our data suggest that neutralizing and nonneutralizing MAbs can interfere with the action of viral neutralization either by inhibition or by enhancement. This report describes the epitope mapping of VZV gps by a functional biological assay.

Full text

PDF
2500

Images in this article

2502Image
on p.2502
2502Image
on p.2502

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burnette W. N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. doi: 10.1016/0003-2697(81)90281-5. [DOI] [PubMed] [Google Scholar]
  2. Chanas A. C., Gould E. A., Clegg J. C., Varma M. G. Monoclonal antibodies to Sindbis virus glycoprotein E1 can neutralize, enhance infectivity, and independently inhibit haemagglutination or haemolysis. J Gen Virol. 1982 Jan;58(Pt 1):37–46. doi: 10.1099/0022-1317-58-1-37. [DOI] [PubMed] [Google Scholar]
  3. Davison A. J., Edson C. M., Ellis R. W., Forghani B., Gilden D., Grose C., Keller P. M., Vafai A., Wroblewska Z., Yamanishi K. New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. J Virol. 1986 Mar;57(3):1195–1197. doi: 10.1128/jvi.57.3.1195-1197.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Edson C. M., Hosler B. A., Poodry C. A., Schooley R. T., Waters D. J., Thorley-Lawson D. A. Varicella-zoster virus envelope glycoproteins: biochemical characterization and identification in clinical material. Virology. 1985 Aug;145(1):62–71. doi: 10.1016/0042-6822(85)90201-6. [DOI] [PubMed] [Google Scholar]
  5. Edson C. M., Hosler B. A., Respess R. A., Waters D. J., Thorley-Lawson D. A. Cross-reactivity between herpes simplex virus glycoprotein B and a 63,000-dalton varicella-zoster virus envelope glycoprotein. J Virol. 1985 Oct;56(1):333–336. doi: 10.1128/jvi.56.1.333-336.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Forghani B., Dupuis K. W., Schmidt N. J. Varicella-zoster viral glycoproteins analyzed with monoclonal antibodies. J Virol. 1984 Oct;52(1):55–62. doi: 10.1128/jvi.52.1.55-62.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Forghani B., Schmidt N. J., Myoraku C. K., Gallo D. Serological reactivity of some monoclonal antibodies to varicella-zoster virus. Arch Virol. 1982;73(3-4):311–317. doi: 10.1007/BF01318084. [DOI] [PubMed] [Google Scholar]
  8. Grose C., Edwards D. P., Friedrichs W. E., Weigle K. A., McGuire W. L. Monoclonal antibodies against three major glycoproteins of varicella-zoster virus. Infect Immun. 1983 Apr;40(1):381–388. doi: 10.1128/iai.40.1.381-388.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Heinz F. X., Berger R., Tuma W., Kunz C. A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology. 1983 Apr 30;126(2):525–537. doi: 10.1016/s0042-6822(83)80010-5. [DOI] [PubMed] [Google Scholar]
  10. Heinz F. X., Berger R., Tuma W., Kunz C. Location of immunodominant antigenic determinants on fragments of the tick-borne encephalitis virus glycoprotein: evidence for two different mechanisms by which antibodies mediate neutralization and hemagglutination inhibition. Virology. 1983 Oct 30;130(2):485–501. doi: 10.1016/0042-6822(83)90102-2. [DOI] [PubMed] [Google Scholar]
  11. Heinz F. X. Epitope mapping of flavivirus glycoproteins. Adv Virus Res. 1986;31:103–168. doi: 10.1016/s0065-3527(08)60263-8. [DOI] [PubMed] [Google Scholar]
  12. Henchal E. A., Henchal L. S., Thaisomboonsuk B. K. Topological mapping of unique epitopes on the dengue-2 virus NS1 protein using monoclonal antibodies. J Gen Virol. 1987 Mar;68(Pt 3):845–851. doi: 10.1099/0022-1317-68-3-845. [DOI] [PubMed] [Google Scholar]
  13. Keller P. M., Neff B. J., Ellis R. W. Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. J Virol. 1984 Oct;52(1):293–297. doi: 10.1128/jvi.52.1.293-297.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kimura-Kuroda J., Yasui K. Topographical analysis of antigenic determinants on envelope glycoprotein V3 (E) of Japanese encephalitis virus, using monoclonal antibodies. J Virol. 1983 Jan;45(1):124–132. doi: 10.1128/jvi.45.1.124-132.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kingsford L. Enhanced neutralization of La Crosse virus by the binding of specific pairs of monoclonal antibodies to the G1 glycoprotein. Virology. 1984 Jul 30;136(2):265–273. doi: 10.1016/0042-6822(84)90163-6. [DOI] [PubMed] [Google Scholar]
  16. Kingsford L., Ishizawa L. D., Hill D. W. Biological activities of monoclonal antibodies reactive with antigenic sites mapped on the G1 glycoprotein of La Crosse virus. Virology. 1983 Sep;129(2):443–455. doi: 10.1016/0042-6822(83)90182-4. [DOI] [PubMed] [Google Scholar]
  17. Lubeck M., Gerhard W. Conformational changes at topologically distinct antigenic sites on the influenza A/PR/8/34 virus HA molecule are induced by the binding of monoclonal antibodies. Virology. 1982 Apr 15;118(1):1–7. doi: 10.1016/0042-6822(82)90313-0. [DOI] [PubMed] [Google Scholar]
  18. Massey R. J., Schochetman G. Topographical analysis of viral epitopes using monoclonal antibodies: mechanism of virus neutralization. Virology. 1981 Nov;115(1):20–32. doi: 10.1016/0042-6822(81)90085-4. [DOI] [PubMed] [Google Scholar]
  19. Massey R. J., Schochetman G. Viral epitopes and monoclonal antibodies: isolation of blocking antibodies that inhibit virus neutralization. Science. 1981 Jul 24;213(4506):447–449. doi: 10.1126/science.6264601. [DOI] [PubMed] [Google Scholar]
  20. McCullough K. C., Crowther J. R., Butcher R. N. A liquid-phase ELISA and its use in the identification of epitopes on foot-and-mouth disease virus antigens. J Virol Methods. 1985 Aug;11(4):329–338. doi: 10.1016/0166-0934(85)90026-6. [DOI] [PubMed] [Google Scholar]
  21. McCullough K. C., Crowther J. R., Carpenter W. C., Brocchi E., Capucci L., De Simone F., Xie Q., McCahon D. Epitopes on foot-and-mouth disease virus particles. I. Topology. Virology. 1987 Apr;157(2):516–525. doi: 10.1016/0042-6822(87)90294-7. [DOI] [PubMed] [Google Scholar]
  22. Montalvo E. A., Grose C. Neutralization epitope of varicella zoster virus on native viral glycoprotein gp118 (VZV glycoprotein gpIII). Virology. 1986 Mar;149(2):230–241. doi: 10.1016/0042-6822(86)90124-8. [DOI] [PubMed] [Google Scholar]
  23. Najjar J. A., Gentsch J. R., Nathanson N., Gonzalez-Scarano F. Epitopes of the G1 glycoprotein of La Crosse virus form overlapping clusters within a single antigenic site. Virology. 1985 Jul 30;144(2):426–432. doi: 10.1016/0042-6822(85)90283-1. [DOI] [PubMed] [Google Scholar]
  24. Okuno T., Yamanishi K., Shiraki K., Takahashi M. Synthesis and processing of glycoproteins of Varicella-Zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens. Virology. 1983 Sep;129(2):357–368. doi: 10.1016/0042-6822(83)90175-7. [DOI] [PubMed] [Google Scholar]
  25. Parekh B. S., Buchmeier M. J. Proteins of lymphocytic choriomeningitis virus: antigenic topography of the viral glycoproteins. Virology. 1986 Sep;153(2):168–178. doi: 10.1016/0042-6822(86)90020-6. [DOI] [PubMed] [Google Scholar]
  26. Schmidt N. J., Lennette E. H. Improved yields of cell-free varicella-zoster virus. Infect Immun. 1976 Sep;14(3):709–715. doi: 10.1128/iai.14.3.709-715.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schmidt N. J., Lennette E. H. Neutralizing antibody responses to varicella-zoster virus. Infect Immun. 1975 Sep;12(3):606–613. doi: 10.1128/iai.12.3.606-613.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shaw R. D., Vo P. T., Offit P. A., Coulson B. S., Greenberg H. B. Antigenic mapping of the surface proteins of rhesus rotavirus. Virology. 1986 Dec;155(2):434–451. doi: 10.1016/0042-6822(86)90205-9. [DOI] [PubMed] [Google Scholar]
  29. Spriggs D. R., Kaye K., Fields B. N. Topological analysis of the reovirus type 3 hemagglutinin. Virology. 1983 May;127(1):220–224. doi: 10.1016/0042-6822(83)90385-9. [DOI] [PubMed] [Google Scholar]
  30. Stone M. R., Nowinski R. C. Topological mapping of murine leukemia virus proteins by competition-binding assays with monoclonal antibodies. Virology. 1980 Jan 30;100(2):370–381. doi: 10.1016/0042-6822(80)90528-0. [DOI] [PubMed] [Google Scholar]
  31. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Vafai A., Wroblewska Z., Mahalingam R., Cabirac G., Wellish M., Cisco M., Gilden D. Recognition of similar epitopes on varicella-zoster virus gpI and gpIV by monoclonal antibodies. J Virol. 1988 Aug;62(8):2544–2551. doi: 10.1128/jvi.62.8.2544-2551.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Vafai A., Wroblewska Z., Wellish M., Green M., Gilden D. Analysis of three late varicella-zoster virus proteins, a 125,000-molecular-weight protein and gp1 and gp3. J Virol. 1984 Dec;52(3):953–959. doi: 10.1128/jvi.52.3.953-959.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES